Ligand validation:2HCJ

TAC: TETRACYCLINE

TAC is a Ligand Of Interest in 2HCJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2HCJ_TAC_B_888	79%	14%	0.124	0.97	2.72	1.17	11	5	2	0	100%	1
2HDN_TAC_H_4888	39%	8%	0.207	0.915	3.22	1.42	16	9	2	0	100%	0.77
6FPL_TAC_A_301	92%	22%	0.062	0.95	1.71	1.53	5	7	0	0	100%	1
5J7L_TAC_AA_1680	60%	57%	0.13	0.916	0.53	1.12	-	2	0	0	100%	1
4V9A_TAC_CA_1805	59%	24%	0.112	0.894	1.49	1.61	5	7	5	0	100%	1
4B3A_TAC_A_222	59%	28%	0.116	0.898	1.51	1.39	7	4	0	0	100%	1
2VKE_TAC_A_222	52%	11%	0.109	0.864	1.9	2.33	6	16	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.